New Cohere Health Solution Aims to Streamline Clinical Reviews for Payers
Cohere Health introduced a new tool for payers called Review Assist. It is meant to…
New Cohere Health Solution Aims to Streamline Clinical Reviews for Payers
Cohere Health introduced a new tool for payers called Review Assist. It is meant to support health plan clinical staff with prior authorization reviews and other use cases. The post New Cohere Health Solution Aims to Streamline Clinical Reviews for Payers appeared first on MedCity News.
Precision Medicine Firm Caris Breaks Bio IPO Drought, Raising $494M for Cancer Analysis Tools
Caris Life Sciences applies AI and machine learning to patient samples to detect cancer and as a companion diagnostic guiding the use of targeted cancer therapies. As a commercial-stage company, Caris’s upsized public markets debut is an outlier amid the continuing IPO freeze for clinical-stage biotechs developing new drugs. The post Precision Medicine Firm Caris…
Why Intermountain Health Is Investing In AI for Clinical Data Abstraction
Intermountain Health is deploying Layer Health’s AI engine for clinical data abstraction across several of its patient registries. The health system’s venture capital arm is also making a strategic investment in the startup. The post Why Intermountain Health Is Investing In AI for Clinical Data Abstraction appeared first on MedCity News.
What OpenAI’s o3 Price Drop Means for the Future of AI in Healthcare?
To be clear, this doesn’t mean healthcare organizations should adopt LLMs tomorrow. But what’s changed is that the primary obstacle – cost at scale – is no longer the immovable obstacle it once was. For healthcare leaders who have been watching the AI wave from the sidelines, this is the moment to move from curiosity…
The MFN Executive Order: A Global Reset for U.S. Pharma
It’s a bold attempt to recalibrate global drug pricing — with U.S. patients at the center. But without clear enforcement, legal grounding, or international cooperation, its future remains very uncertain. The post The MFN Executive Order: A Global Reset for U.S. Pharma appeared first on MedCity News.
Weekend Reading
Impact of ‘One Big Beautiful Bill’ on rural hospital financesBrain implant lets patient with ALS speak and singImpact of children’s disability on parent’s mental health.COVID is back?How does this man defy aging?
An empirical test for the Fair Innings hypothesis
Suppose you have a single pill at your disposal and that pill will extend any person’s life by 10 years. You have to choose to give it to one of the following tow individuals: a 20‐year‐old patient, who will live for 10 more years if she gets the drug, and then she dies;a 70‐year‐old patient,…
Bluebird Kids Health to Expand By Opening New Pediatric Clinics
Just a year after its launch, Bluebird Kids Health is already announcing plans to double its number of pediatric clinics. The startup seeks to improve pediatric care access in underserved areas by building practices in these neighborhoods and accepting all insurance types. The post Bluebird Kids Health to Expand By Opening New Pediatric Clinics appeared…
Sword Health Raises $40M, Launches Mental Health Solution
Sword Health’s $40 million funding round was led by General Catalyst. In total, the company has raised $300 million. The most recent round brings its valuation to $4 billion. The post Sword Health Raises $40M, Launches Mental Health Solution appeared first on MedCity News.
Senate Finance Language Would Further Cut Federal Spending for Medicaid Expansion States
Prior KFF analysis allocated CBO’s federal Medicaid spending reductions and enrollment losses across the states, and this policy watch builds on that analysis to examine the potential impacts in expansion states compared with non-expansion states.
